查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1615472

全球生长因子市场：按类型、来源、传递方法、分销管道、应用、治疗领域 - 预测 2025-2030

Growth Factors Market by Type, Source, Delivery Method, Distribution Channel, Application, Therapeutic Area - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生长因子市场规模为18.5亿美元，预计2024年将达到19.8亿美元，复合年增长率为7.17%，2030年将达到30.1亿美元。

市场研究中的成长因素通常是指推动特定市场扩张的因素。这包括技术进步、不断变化的消费行为、监管变化、经济状况等。作为360iResearch的市场研究分析师，了解这些因素非常重要，因为它定义了市场潜力并有助于策略规划。这些成长因素对于评估市场需求、设定可实现的业务目标和识别新兴趋势是必要的。它还可以应用于行销策略制定、产品开拓、市场竞争分析等。最终用途范围包括技术、医疗保健、零售和金融等行业，这些行业在很大程度上依赖此类见解来保持领先地位。

主要市场统计
基准年[2023] 18.5亿美元
预测年份 [2024] 19.8亿美元
预测年份 [2030] 30.1亿美元
复合年增长率（%） 7.17%

在市场洞察方面，技术进步成为主要的成长影响因素，为人工智慧主导的分析和个人化客户服务等领域提供了机会。不断变化的法规环境既带来了挑战，也带来了机会。如果公司能够快速适应，他们就可以利用变革来获得竞争优势。影响消费者购买力的经济趋势也很重要，需要积极调整策略。在数位转型和永续性方面发现了最新的潜在商机，鼓励企业利用绿色解决方案和数位平台进行创新。将鼓励对提高效率和减少环境影响的技术进行投资。

然而，资料隐私问题、某些领域的市场饱和以及世界事件的不可预测性等限制可能会抑製成长。公司必须透过投资强大的网路安全、多样化投资组合併确保营运灵活性来应对这些挑战。竞争加剧和消费者偏好快速变化等竞争因素需要持续监控和调整策略。潜在的创新领域包括开发更聪明的演算法来进行即时资料分析，以及创造更身临其境的虚拟客户体验。由于市场的本质仍然是动态和竞争的，公司必须优先考虑创新和敏捷性，以捕捉成长并在不断变化的环境中保持弹性。

市场动态：揭示快速发展的生长因子市场的关键市场洞察

供给和需求的动态交互作用正在改变生长因子市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 对再生医学的需求不断增加，以因应慢性病的增加
    • 消费者对个人化和量身定制的医疗保健策略的偏好不断增加
    • 扩大组织工程、干细胞和再生治疗的研究活动
  • 市场限制因素
    • 规模化和製造成长因素的复杂性
  • 市场机会
    • 改进生技药品製造流程并更有效地生产生技药品
    • 扩大生长因子在化妆品应用上的使用
  • 市场挑战
    • 对生长因子安全性和有效性的担忧

波特五力：驾驭生长因子市场的策略工具

波特的五力架构是了解生长因子市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解生长因子市场的外部影响

外部宏观环境因素对于塑造生长因子市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 成长因素 了解市场竞争状况

成长因素市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵成长因素市场供应商的绩效评估

FPNV 定位矩阵是评估成长因子市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和推荐的成长因素描绘了市场成功之路

生长因子市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人们越来越需要再生医学来应对慢性疾病的增加。
      • 消费者对个人化和客製化医疗保健策略的偏好日益增长
      • 扩大组织工程、干细胞和再生医学领域的研究活动
    • 抑制因素
      • 生长因子缩放和製造复杂性
    • 机会
      • 改进生物製造製程并更有效地生产生技药品
      • 扩大生长因子在化妆品领域的应用
    • 任务
      • 对生长因子安全性和有效性的担忧
  • 市场区隔分析
    • 类型：表皮生长因子的使用由于其在眼科和创伤治疗中的作用而不断增加
    • 应用：生长因子在治疗增加慢性病的巨大潜力
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章生长因子市场：依类型

  • 表皮生长因子
  • 纤维母细胞生长因子
  • 肝细胞生长因子
  • 类胰岛素生长因子
  • 神经生长因子
  • 血小板衍生生长因子
  • 转化生长因子
  • 血管内皮生长因子

第七章生长因子市场：依来源分类

  • 动物源性生长因子
  • 人源性生长因子

第八章按交付方式分類的生长因子市场

  • 注射给药
  • 口服给药
  • 局部给药

第九章生长因子市场：按通路

  • 离线
  • 在线的

第10章生长因子市场：依应用分类

  • 化妆品
    • 头髮护理
    • 护肤
  • 药品
    • 癌症治疗
    • 组织再生
    • 伤口癒合
  • 调查
    • 细胞培养基
    • 药物发现

第十一章依治疗领域分類的生长因子市场

  • 心血管疾病
  • 皮肤科
  • 神经系统疾病
  • 肿瘤学
  • 眼科
  • 整形外科

第十二章美洲生长因子市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十三章亚太生长因子市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十四章欧洲、中东和非洲的生长因子市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Biocon Biologics Limited 的生物相似药阿柏西普获得 FDA核准
    • ABenz Therapeutics 获得 1.5 亿美元资金，用于加强肿瘤产品线并推进药物开发
    • 丹纳赫公司已完成对 Abcam Limited 的收购，以加强其生命科学产品组合。
  • 战略分析和建议

公司名单

  • Abcam PLC by Danaher Corporation
  • Akron Biotech
  • Applied Biological Materials Inc.
  • Bio-Techne Corporation
  • Biopharm GmbH
  • Cell Guidance Systems LLC
  • Cell Signaling Technology, Inc.
  • Creative Bioarray
  • F. Hoffmann-La Roche AG
  • Gemini BioProducts LLC
  • Johnson & Johnson Services, Inc.
  • Leadgene Biomedical, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Meridian Bioscience Inc.
  • Miltenyi Biotec BV & Co. KG
  • Prospec-Tany Technogene Ltd.
  • Proteintech Group, Inc.
  • Repligen Corporation
  • Reprocell Inc.
  • Rockland Immunochemicals, Inc.
  • Sartorius AG
  • Sino Biological, Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-8E22B619330C

The Growth Factors Market was valued at USD 1.85 billion in 2023, expected to reach USD 1.98 billion in 2024, and is projected to grow at a CAGR of 7.17%, to USD 3.01 billion by 2030.

Growth factors in market research typically refer to the elements driving the expansion of a particular market. These can include technological advancements, evolving consumer behaviors, regulatory changes, and economic conditions. In the role of a Market Research Analyst at 360iResearch, understanding these factors is crucial as they define the market's potential and help in strategic planning. These growth factors are necessary for assessing market demands, setting feasible business goals, and identifying emerging trends. They have applications in formulating marketing strategies, product development, and competitive analysis. The end-use scope includes industries like technology, healthcare, retail, and finance, which heavily rely on such insights to stay ahead.

KEY MARKET STATISTICS
Base Year [2023] USD 1.85 billion
Estimated Year [2024] USD 1.98 billion
Forecast Year [2030] USD 3.01 billion
CAGR (%) 7.17%

In terms of market insights, technological advancements stand out as a significant growth influencer, offering opportunities in areas such as AI-driven analytics and personalized customer interactions. The ever-evolving regulatory environment presents both challenges and opportunities; companies can leverage changes for competitive advantage if they can quickly adapt. Economic trends that influence consumer purchasing power are also critical, necessitating proactive adjustments in strategies. The latest potential opportunities are seen in digital transformation and sustainability, with businesses encouraged to innovate in eco-friendly solutions and digital platforms. A recommendation would be to invest in technology that enhances efficiency and reduces environmental impact.

However, limitations such as data privacy concerns, market saturation in certain sectors, and the unpredictability of global events can deter growth. Companies must navigate these by investing in robust cybersecurity, diversifying portfolios, and ensuring agile operations. Challenging factors like fierce competition and rapidly changing consumer preferences demand continuous monitoring and adaptation of strategies. Potential areas for innovation include developing smarter algorithms for real-time data analysis and creating more immersive virtual customer experiences. The nature of the market remains dynamic and competitive, necessitating businesses to prioritize innovation and agility to capture growth and maintain resilience in a constantly shifting landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Growth Factors Market

The Growth Factors Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising need for regenerative medicines to manage the increasing prevalence of chronic diseases
    • Growing consumer preference for personalized and tailored healthcare strategies
    • Expanding research activities in tissue engineering, stem cell, and regenerative therapies
  • Market Restraints
    • Complexities in scaling and manufacturing of growth factors
  • Market Opportunities
    • Improvements in biomanufacturing processes and more efficient production of biologics
    • Expanding usage of growth factors in cosmetic applications
  • Market Challenges
    • Safety and efficacy concerns of growth factor

Porter's Five Forces: A Strategic Tool for Navigating the Growth Factors Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Growth Factors Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Growth Factors Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Growth Factors Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Growth Factors Market

A detailed market share analysis in the Growth Factors Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Growth Factors Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Growth Factors Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Growth Factors Market

A strategic analysis of the Growth Factors Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Growth Factors Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC by Danaher Corporation, Akron Biotech, Applied Biological Materials Inc., Bio-Techne Corporation, Biopharm GmbH, Cell Guidance Systems LLC, Cell Signaling Technology, Inc., Creative Bioarray, F. Hoffmann-La Roche AG, Gemini BioProducts LLC, Johnson & Johnson Services, Inc., Leadgene Biomedical, Inc., Lonza Group Ltd., Merck KGaA, Meridian Bioscience Inc., Miltenyi Biotec B.V. & Co. KG, Prospec-Tany Technogene Ltd., Proteintech Group, Inc., Repligen Corporation, Reprocell Inc., Rockland Immunochemicals, Inc., Sartorius AG, Sino Biological, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Growth Factors Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Epidermal Growth Factor, Fibroblast Growth Factor, Hepatocyte Growth Factor, Insulin-like Growth Factor, Nerve Growth Factor, Platelet-Derived Growth Factor, Transforming Growth Factor, and Vascular Endothelial Growth Factor.
  • Based on Source, market is studied across Animal-derived Growth Factors and Human-derived Growth Factors.
  • Based on Delivery Method, market is studied across Injectable Administration, Oral Administration, and Topical Administration.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on Application, market is studied across Cosmetic, Medical, and Research. The Cosmetic is further studied across Hair Care and Skin Care. The Medical is further studied across Cancer Treatment, Tissue Regeneration, and Wound Healing. The Research is further studied across Cell Culture Media and Drug Discovery.
  • Based on Therapeutic Area, market is studied across Cardiovascular Diseases, Dermatology, Neurological Disorders, Oncology, Ophthalmology, and Orthopedics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising need for regenerative medicines to manage the increasing prevalence of chronic diseases
      • 5.1.1.2. Growing consumer preference for personalized and tailored healthcare strategies
      • 5.1.1.3. Expanding research activities in tissue engineering, stem cell, and regenerative therapies
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities in scaling and manufacturing of growth factors
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvements in biomanufacturing processes and more efficient production of biologics
      • 5.1.3.2. Expanding usage of growth factors in cosmetic applications
    • 5.1.4. Challenges
      • 5.1.4.1. Safety and efficacy concerns of growth factor
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing usage of epidermal growth factor due to its roles in ophthalmology and wound healing
    • 5.2.2. Application: High potential of growth factors in medical for treating growing number of chronic diseases
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Growth Factors Market, by Type

  • 6.1. Introduction
  • 6.2. Epidermal Growth Factor
  • 6.3. Fibroblast Growth Factor
  • 6.4. Hepatocyte Growth Factor
  • 6.5. Insulin-like Growth Factor
  • 6.6. Nerve Growth Factor
  • 6.7. Platelet-Derived Growth Factor
  • 6.8. Transforming Growth Factor
  • 6.9. Vascular Endothelial Growth Factor

7. Growth Factors Market, by Source

  • 7.1. Introduction
  • 7.2. Animal-derived Growth Factors
  • 7.3. Human-derived Growth Factors

8. Growth Factors Market, by Delivery Method

  • 8.1. Introduction
  • 8.2. Injectable Administration
  • 8.3. Oral Administration
  • 8.4. Topical Administration

9. Growth Factors Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Growth Factors Market, by Application

  • 10.1. Introduction
  • 10.2. Cosmetic
    • 10.2.1. Hair Care
    • 10.2.2. Skin Care
  • 10.3. Medical
    • 10.3.1. Cancer Treatment
    • 10.3.2. Tissue Regeneration
    • 10.3.3. Wound Healing
  • 10.4. Research
    • 10.4.1. Cell Culture Media
    • 10.4.2. Drug Discovery

11. Growth Factors Market, by Therapeutic Area

  • 11.1. Introduction
  • 11.2. Cardiovascular Diseases
  • 11.3. Dermatology
  • 11.4. Neurological Disorders
  • 11.5. Oncology
  • 11.6. Ophthalmology
  • 11.7. Orthopedics

12. Americas Growth Factors Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Growth Factors Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Growth Factors Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Biocon Biologics Limited secured FDA approval for biosimilar aflibercept
    • 15.3.2. Avenzo Therapeutics secured USD 150 million to boost oncology pipeline and advance drug development
    • 15.3.3. Danaher Corporation completed the acquisition of Abcam Limited to enhance life sciences portfolio
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC by Danaher Corporation
  • 2. Akron Biotech
  • 3. Applied Biological Materials Inc.
  • 4. Bio-Techne Corporation
  • 5. Biopharm GmbH
  • 6. Cell Guidance Systems LLC
  • 7. Cell Signaling Technology, Inc.
  • 8. Creative Bioarray
  • 9. F. Hoffmann-La Roche AG
  • 10. Gemini BioProducts LLC
  • 11. Johnson & Johnson Services, Inc.
  • 12. Leadgene Biomedical, Inc.
  • 13. Lonza Group Ltd.
  • 14. Merck KGaA
  • 15. Meridian Bioscience Inc.
  • 16. Miltenyi Biotec B.V. & Co. KG
  • 17. Prospec-Tany Technogene Ltd.
  • 18. Proteintech Group, Inc.
  • 19. Repligen Corporation
  • 20. Reprocell Inc.
  • 21. Rockland Immunochemicals, Inc.
  • 22. Sartorius AG
  • 23. Sino Biological, Inc.
  • 24. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GROWTH FACTORS MARKET RESEARCH PROCESS
  • FIGURE 2. GROWTH FACTORS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GROWTH FACTORS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GROWTH FACTORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GROWTH FACTORS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GROWTH FACTORS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GROWTH FACTORS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GROWTH FACTORS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES GROWTH FACTORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES GROWTH FACTORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. GROWTH FACTORS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. GROWTH FACTORS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GROWTH FACTORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GROWTH FACTORS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GROWTH FACTORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GROWTH FACTORS MARKET DYNAMICS
  • TABLE 7. GLOBAL GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GROWTH FACTORS MARKET SIZE, BY EPIDERMAL GROWTH FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GROWTH FACTORS MARKET SIZE, BY FIBROBLAST GROWTH FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GROWTH FACTORS MARKET SIZE, BY HEPATOCYTE GROWTH FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GROWTH FACTORS MARKET SIZE, BY INSULIN-LIKE GROWTH FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GROWTH FACTORS MARKET SIZE, BY NERVE GROWTH FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GROWTH FACTORS MARKET SIZE, BY PLATELET-DERIVED GROWTH FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GROWTH FACTORS MARKET SIZE, BY VASCULAR ENDOTHELIAL GROWTH FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GROWTH FACTORS MARKET SIZE, BY ANIMAL-DERIVED GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GROWTH FACTORS MARKET SIZE, BY HUMAN-DERIVED GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GROWTH FACTORS MARKET SIZE, BY INJECTABLE ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GROWTH FACTORS MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GROWTH FACTORS MARKET SIZE, BY TOPICAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GROWTH FACTORS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GROWTH FACTORS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GROWTH FACTORS MARKET SIZE, BY COSMETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GROWTH FACTORS MARKET SIZE, BY HAIR CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GROWTH FACTORS MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GROWTH FACTORS MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GROWTH FACTORS MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GROWTH FACTORS MARKET SIZE, BY TISSUE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GROWTH FACTORS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL GROWTH FACTORS MARKET SIZE, BY CELL CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL GROWTH FACTORS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL GROWTH FACTORS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL GROWTH FACTORS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL GROWTH FACTORS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL GROWTH FACTORS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL GROWTH FACTORS MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL GROWTH FACTORS MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES GROWTH FACTORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. INDONESIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 146. INDONESIA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. JAPAN GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 155. JAPAN GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 157. JAPAN GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. MALAYSIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. MALAYSIA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 164. MALAYSIA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 165. MALAYSIA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 166. MALAYSIA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 173. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 174. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 175. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. SINGAPORE GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. SINGAPORE GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 182. SINGAPORE GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 183. SINGAPORE GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 184. SINGAPORE GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 189. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 191. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 192. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 193. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 198. TAIWAN GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. TAIWAN GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 200. TAIWAN GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 201. TAIWAN GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 202. TAIWAN GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 207. THAILAND GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. THAILAND GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 209. THAILAND GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 210. THAILAND GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 211. THAILAND GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. VIETNAM GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. VIETNAM GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 218. VIETNAM GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 219. VIETNAM GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 220. VIETNAM GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. DENMARK GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. DENMARK GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 237. DENMARK GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 238. DENMARK GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 239. DENMARK GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 244. EGYPT GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. EGYPT GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 246. EGYPT GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 247. EGYPT GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 248. EGYPT GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 253. FINLAND GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. FINLAND GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 255. FINLAND GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 256. FINLAND GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 257. FINLAND GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 262. FRANCE GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. FRANCE GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 264. FRANCE GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 265. FRANCE GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 266. FRANCE GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 271. GERMANY GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. GERMANY GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 273. GERMANY GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 274. GERMANY GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 275. GERMANY GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 280. ISRAEL GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 281. ISRAEL GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 282. ISRAEL GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 283. ISRAEL GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 284. ISRAEL GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 287. ITALY GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 289. ITALY GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. ITALY GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 291. ITALY GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 292. ITALY GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 293. ITALY GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 297. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 298. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 299. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 300. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 301. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 302. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 306. NIGERIA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 307. NIGERIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 308. NIGERIA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 309. NIGERIA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 310. NIGERIA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 311. NIGERIA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 315. NORWAY GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 316. NORWAY GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 317. NORWAY GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 318. NORWAY GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 319. NORWAY GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 320. NORWAY GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 323. POLAND GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 324. POLAND GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 325. POLAND GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. POLAND GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 327. POLAND GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 328. POLAND GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 329. POLAND GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 330. QATAR GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 331. QATAR GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 332. QATAR GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 333. QATAR GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 334. QATAR GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 335. QATAR GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 336. QATAR GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 337. QATAR GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 338. QATAR GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 339. RUSSIA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 340. RUSSIA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 341. RUSSIA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 342. RUSSIA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 343. RUSSIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 344. RUSSIA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 345. RUSSIA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 346. RUSSIA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 347. RUSSIA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 348. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 349. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 350. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 351. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 352. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 353. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 354. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 355. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 356. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 357. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 358. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 359. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 360. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 361. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 362. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 363. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 364. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 365. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 366. SPAIN GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 367. SPAIN GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 368. SPAIN GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 369. SPAIN GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 370. SPAIN GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 371. SPAIN GROWTH FACTORS MARKET SIZE, BY